ATHIRA
Fosgonimeton
This clinical trial examines the long-term tolerability of Fosgonimeton (ATH-1017) over an additional 4-year period in subjects with mild to moderate Alzheimer’s disease. This trial is an extension of Study ATH-1017-AD-0201 and Study ATH-1017-AD-0202.
Status: ACTIVE, NOT RECRUITING